(S)-4-(3-bromophenyl)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline, 98%, 500mg

1-(Phenanthren-3-yl)ethanone, 95.0%, 250mg

Na-Boc-Nb-(2,4-dinitrophenyl)-D-2,3-diaminopropionic acid, 99.0%, 250mg

2,4-Diisopropoxybenzaldehyde, 100mg

3,5-Difluoro-2-trifluoromethyl-aniline, 98.0%, 5g

alpha-Bromodiphenylmethane>97.0%(HPLC)(T)25g

(S)-2-(4-Chlorophenyl)piperidine hydrochloride, 98%, 250mg

2,2-Bis[(4R)-4-isopropyl-2-oxazolin-2-yl]propane, 97%, 5g

4,4,5,5-Tetramethyl-2-(1-methylcyclopropyl)-1,3,2-dioxaborolane, 97%, 1g

2,4-Dichloropyrimidine-5-carbaldehyde, 95.0%, 1g

(R,E)-4-((1R,3aS,7aR,E)-4-((E)-2-((3S,5R)-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-1-cyclopropylpent-2-en-1-one, 98%, 1g

5-(Methoxycarbonyl)-4-(trifluoromethyl)pyrimidine-2-hydrazine, 95.0%, 250mg

3,4-Dimethoxybenzaldehyde, min. 99%, for synthesis, 500 g, plastic packaging.